Secretion of recombinant human fibrinogen by the murine mammary gland

Transgenic Research

Volumn 13, Issue 5, 2004, Pages 437-450

  Butler, Stephen ^a   O'Sickey, Tanya ^a   Lord, Susan ^b   Lubon, Henryk ^c   Gwazdauskas, Francis ^a   Velander, William ^d  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c AMERICAN RED CROSS   (United States)

^d UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Mammary gland expression; Recombinant human fibrinogen; Transgenic mouse; WAP promoter

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; MILK PROTEIN; RECOMBINANT PROTEIN; THROMBIN; WHEY ACIDIC PROTEINS;

ANIMAL; ARTICLE; FEMALE; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; MILK; MOUSE; PROMOTER REGION; SECRETION; TRANSGENIC MOUSE; UDDER;

ANIMALS; FACTOR XIII; FEMALE; FIBRINOGEN; GLYCOSYLATION; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK; MILK PROTEINS; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; THROMBIN;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 7244238182     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-004-9589-8     Document Type: Article

References (35)

1. Alving BM, Weinstein MJ, Finlayson JS, Menitove JE and Frantantoni JC (1995) Fibrin sealant: summary of a conference on characteristics and clinical uses. Transfusion 35:783-790.
2. Burdon T, Sankaran L, Wall R, Spencer M and Hennighausen L (1991) Expression of a whey acidic protein transgene during mammary development. J Biol Chem 266: 6909-6914.
3. Butler S, van Cott K, Subramanian A, Gwazdauskas F and Velander W (1997) Current progress in the production of recombinant human fibrinogen in the milk of transgenic animals. Thromb Haemoslasis 78(1):537-542.
4. Canseco RS, Sparks AET, Page RL, Russell CG, Johnson JL, Velander WH et al. (1994) Gene transfer efficiency during gestation and the influence of co-transfer of non-manipulated embryos on production of transgenic mice. Transgenic Res 3: 20-25.
5. Chung DW, Que BG, Rixon MW, Mace M and Davie EW. (1983a) Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the beta chain of human fibrinogen. Biochem 22: 3244-3250.
6. Chung DW, Chan W and Davie EW (1983b) Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen. Biochem 22: 3250-3256.
7. Cottingham I, McKee C, Temperley S, Garner I, Prunkard D, Lasser G et al. (1997) Human fibrinogen from the milk of transgenic sheep. In: Tissue Sealants: Current Practice, Future Uses. Cambridge Healthtech Institute, Newton Upper Fall, MA.
8. Danishefsky K, Hartwig R, Banerjee D and Redman C (1990) Intracellular fate of fibrinogen Bβ chain expressed in COS cells. Biochem Biophy Acta 1048: 202-208.
9. 2+-selective purification of recombinant proteins from the milk of transgenic animals. J Chromatogr. A 799:125-137.
10. Doolittle RF (1984) Fibrinogen and fibrin. Annu Rev Biochem 53: 195-229.
11. Drohan WN and Clark DB (2000) Progress in transgenic production of human plasma proteins in mammary bioreactors. J Anim Sci 78 (Suppl. 3): 1-7.
12. Fink PS (1991) Short technical report. BioTech 10: 446-450.
13. Greco F, de Palma L, Spagnolo N, Rossi A, Specchia N and Gigante A (1991) Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. J Biomed Mat Res 25: 39-51.
14. Hartwig R and Danishefsky KJ (1991) Studies on the assembly and secretion of fibrinogen. J Biol Chem 266: 6578-6585.
15. Hogan B, Constantini F and Lacy E (1986) Manipulating the Mouse Embryo: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
16. Huang S, Mulvihill ER, Farrell DH, Chung DW and Davie EW (1993) Biosynthesis of human fibrinogen. J Biol Chem 268: 4919-4926.
17. Huang S, Cao Z, Chung DW and Davie EW (1996) The role of βγ and αγ complexes in the assembly of human fibrinogen. J Biol Chem 271: 27942-27947.
18. Hui X and Redman CM (2001) Differential degradation of the three fibrinogen chains by proteasomes: involvement of Sec61p and cytosolic Hsp 70. Arch Biochem Biophys 390: 137-145.
19. Lasa C, Hollinger J, Drohan W and MacPhee M (1996) Bone induction by demineralized bone powder and partially purified osteogenin using a fibrin-sealant carrier. In: Sierra D and Saltz R (eds) Surgical Adhesives and Sealants: Current Technology and Applications. Technomic Publishing Co. Lancaster, PA.
20. MacPhee M, Campagna A, Kidd R, Best A and Drohan WN (1996a) Fibrin sealant as a delivery vehicle for sustained and controlled release of chemotherapy agents. In: Sierra D and Saltz R (eds) Surgical Adhesives and Sealants: Current Technology and Applications. Technomic Publishing Co., Lancaster, PA
21. MacPhee M, Nunez H, Hennings R, Campagna A, Grummon G, Harding S et al. (1996b) Sustained release in vitro and in vivo of antibiotics from fibrin sealant: In: Sierra D and Saltz R (eds) Surgical Adhesives and Sealants: Current Technology and Applications. Technomic Publishing Co., Lancaster, PA.
22. McKnight RA, Wall RJ and Hennighausen L (1995) Expression of genomic and cDNA transgenes after co-integration in transgenic mice. Transgenic Res 4: 39-43.
23. Prunkard D, Cottingham, Garner I, Bruce S, Dalrymple M et al. (1996) High-level expression of recombinant human fibrinogen in the milk of transgenic mice. Nature Biotech 14: 867-871
24. Rixon MW, Chan W, Davie EW and Chung DW (1983) Characterization of a complementary deoxyribonucleic acid coding for the alpha chain of human fibrinogen. Biochem 22: 3237-3244.
25. Roy SN, Mukhopadhyay G and Redman C (1990) Regulation of fibrinogen assembly. J Biol Chem 265: 6389-6393.
26. Roy SN, Procyk R, Kudryk BJ and Redman C (1991) Assembly and secretion of recombinant human fibrinogen. J Biol Chem 266: 4758-4763.
27. Roy S, Overton O and Redman C (1994) Overexpression of any fibrinogen chain by HepG2 cells specifically elevates the expression of the other two chains. J Biol Chem 269: 691-695.
28. Saiki RK, Walsh PS, Levenson CH and Erlich HA (1989) Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acal Sci USA 86: 6230-6234.
29. Van Cott KE, Lubon H, Russell CG, Butler SP, Gwazdauskas FC et al. (1997) Phenotypic and genotypic stablity of multiple lines of transgenic pigs expressing recombinant human protein C. Transgenic Res 6: 1-10
30. Velander WH, Lubon H and Drohan WN (1996) Transgenic livestock as drug factories. Sci Am 276: 70-74.
31. Velander WH, Page RL, Morcol T, Russell CG, Canseco R et al. (1992) Production of biologically active human Protein C in the milk of transgenic mice. Annu NY Acad Sci 665: 391-403.
32. Xia H and CM Redman (2001) Differential degradation of the three fibrinogen chains by proteasomes: involvement on Sec61p and cytosolic Hsp70. Arch Biochem Biophys 390: 137-145.
33. Yu S, Sher B, Kudryk B and Redman CM (1983) Intracellular assembly of human fibrinogen. J Biol Chem 258: 13407-13410.
34. Yu S, Sher B, Kudryk B and Redman CM (1984) Fibrinogen precursors order of assembly of fibrinogen chains. J Biol Chem 259: 10574-10581.
35. Zhang J and Redman CM (1996) Assembly and secretion of fibrinogen. J Biol Chem 271: 12674-12680.